Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor Richard Baffour, PhD, Joel Berman, MD, Jane L. Garb, MS, Sang Won Rhee, MD, Jeffrey Kaufman, MD, Paul Friedmann, MD Journal of Vascular Surgery Volume 16, Issue 2, Pages 181-191 (August 1992) DOI: 10.1016/0741-5214(92)90106-I Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 1 Surgical procedure is shown; second stage is performed 1 week later. Journal of Vascular Surgery 1992 16, 181-191DOI: (10.1016/0741-5214(92)90106-I) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 2 Experimental protocol. Journal of Vascular Surgery 1992 16, 181-191DOI: (10.1016/0741-5214(92)90106-I) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 3 Representative angiograms; Angiographic evidence of revascularization by exogenous bFGF are compared. A, saline control; B, 1 μg bFGF; C, 3 μg bFGF animals. Journal of Vascular Surgery 1992 16, 181-191DOI: (10.1016/0741-5214(92)90106-I) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 4 Comparison of treatment groups on TcPo2 measurements on days 1, 7, and 14. Journal of Vascular Surgery 1992 16, 181-191DOI: (10.1016/0741-5214(92)90106-I) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 5 Representative histologic sections; Left thigh; vastus medialis muscle sections histochemically stained for alkaline phosphatase activity. Dark spots represent capillaries. (A) saline control (× 250); (B) 1 μg bFGF (× 250); (C) 3 μg bFGF (× 250). Journal of Vascular Surgery 1992 16, 181-191DOI: (10.1016/0741-5214(92)90106-I) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 6 Comparison of treatment groups on muscle TTC reduction. Journal of Vascular Surgery 1992 16, 181-191DOI: (10.1016/0741-5214(92)90106-I) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions